| scholarly article | Q13442814 |
| P50 | author | Mohd Aqil | Q42413205 |
| P2093 | author name string | Himanshu Gupta | |
| Gaurav Mittal | |||
| Asgar Ali | |||
| Aseem Bhatnagar | |||
| Roop K Khar | |||
| P433 | issue | 2 | |
| P921 | main subject | nanotechnology | Q11468 |
| nanoparticle | Q61231 | ||
| drug delivery | Q1392806 | ||
| P304 | page(s) | 324-333 | |
| P577 | publication date | 2009-10-23 | |
| P1433 | published in | Nanomedicine: Nanotechnology, Biology and Medicine | Q6964073 |
| P1476 | title | Sparfloxacin-loaded PLGA nanoparticles for sustained ocular drug delivery | |
| P478 | volume | 6 |
| Q46616209 | A combined micelle and poly(serinol hexamethylene urea)-co-poly(N-isopropylacrylamide) reverse thermal gel as an injectable ocular drug delivery system |
| Q39170252 | A critical review about methodologies for the analysis of mucoadhesive properties of drug delivery systems. |
| Q38658684 | Advance of the application of nano-controlled release system in ophthalmic drug delivery |
| Q38297129 | Advances in ophthalmic drug delivery. |
| Q36743407 | An Improvement of the Efficacy of Moxifloxacin HCl for the Treatment of Bacterial Keratitis by the Formulation of Ocular Mucoadhesive Microspheres |
| Q29248330 | Antimicrobial Polymers in the Nano-World |
| Q36500235 | Auranofin-loaded nanoparticles as a new therapeutic tool to fight streptococcal infections |
| Q101409984 | Besifloxacin liposomes with positively charged additives for an improved topical ocular delivery |
| Q28538289 | Bimatoprost-loaded ocular inserts as sustained release drug delivery systems for glaucoma treatment: in vitro and in vivo evaluation |
| Q45146497 | Biodegradable levofloxacin nanoparticles for sustained ocular drug delivery |
| Q35161197 | CSM enhances the filtration bleb survival in rabbit model of experimental glaucoma surgery |
| Q90191574 | Characterizing the impact of 2D and 3D culture conditions on the therapeutic effects of human mesenchymal stem cell secretome on corneal wound healing in vitro and ex vivo |
| Q35727894 | Chitosan grafted methoxy poly(ethylene glycol)-poly(ε-caprolactone) nanosuspension for ocular delivery of hydrophobic diclofenac |
| Q35981514 | Chondroitin sulfate-chitosan nanoparticles for ocular delivery of bromfenac sodium: Improved permeation, retention, and penetration |
| Q38217270 | Colloidal drug delivery system: amplify the ocular delivery |
| Q41513479 | Comparison of Different Nanosuspensions as Potential Ophthalmic Delivery Systems for Ketotifen Fumarate. |
| Q49275152 | Controlled drug delivery for glaucoma therapy using montmorillonite/Eudragit microspheres as an ion-exchange carrier |
| Q37652843 | Corneal permeation properties of a charged lipid nanoparticle carrier containing dexamethasone |
| Q45343553 | Design and development of a novel pH triggered nanoemulsified in-situ ophthalmic gel of fluconazole: ex-vivo transcorneal permeation, corneal toxicity and irritation testing |
| Q36360549 | Development and Evaluation of Diclofenac Sodium Loaded-N-Trimethyl Chitosan Nanoparticles for Ophthalmic Use. |
| Q92770770 | Development and characterization of oxaceprol-loaded poly-lactide-co-glycolide nanoparticles for the treatment of osteoarthritis |
| Q43610260 | Development and evaluation of a novel in situ gel of sparfloxacin for sustained ocular drug delivery: in vitro and ex vivo characterization |
| Q34957716 | Development of an enhanced formulation for delivering sustained release of buprenorphine hydrochloride |
| Q56904286 | Emerging and re-emerging infectious disease in otorhinolaryngology |
| Q92862376 | Emerging role of nanosuspensions in drug delivery systems |
| Q53604747 | Engineering of polymer-surfactant nanoparticles of doxycycline hydrochloride for ocular drug delivery. |
| Q41196940 | Evaluation of gatifloxacin pluronic micelles and development of its formulation for ocular delivery |
| Q40919415 | Formulation and comparative evaluation of HPMC and water soluble chitosan-based sparfloxacin nanosuspension for ophthalmic delivery. |
| Q53801960 | Formulation and in vitro characterization of poly(dl-lactide-co-glycolide)/Eudragit RLPO or RS30D nanoparticles as an oral carrier of levofloxacin hemihydrate. |
| Q99405111 | Improvement of Ocular Efficacy of Levofloxacin by Bioadhesive Chitosan Coated PLGA Nanoparticles: Box-behnken Design, In-vitro Characterization, Antibacterial Evaluation and Scintigraphy Study |
| Q52773736 | In vitro release testing method development for ophthalmic ointments. |
| Q42817743 | Integrated risk assessment of a hydroxyapatite-protein-composite for use in oral care products: a weight-of-evidence case study |
| Q43025529 | Investigation of moxifloxacin loaded chitosan-dextran nanoparticles for topical instillation into eye: In-vitro and ex-vivo evaluation |
| Q38931354 | Magnetic nanoparticles: a strategy to target the choroidal layer in the posterior segment of the eye |
| Q57368991 | Monitoring the intracellular transformation process of surface-cleavable PLGA particles containing disulfide bonds by fluorescence resonance energy transfer |
| Q86182441 | Montmorillonite clay based polyurethane nanocomposite as substrate for retinal pigment epithelial cell growth |
| Q44384393 | Naltrexone-loaded poly[La-(Glc-Leu)] polymeric microspheres for the treatment of alcohol dependence: in vitro characterization and in vivo biocompatibility assessment |
| Q38003088 | Nanomaterials for ocular drug delivery |
| Q38120319 | Nanomedicine strategies for drug delivery to the ear. |
| Q42433058 | Nanoparticle-Laden Contact Lens for Controlled Ocular Delivery of Prednisolone: Formulation Optimization Using Statistical Experimental Design |
| Q38878972 | Nanoparticles as tool for enhanced ophthalmic delivery of vancomycin: a multidistrict-based microbiological study, solid lipid nanoparticles formulation and evaluation. |
| Q39230212 | Nanoparticles for drug delivery to the anterior segment of the eye. |
| Q41448124 | Nanoparticles laden in situ gel for sustained ocular drug delivery |
| Q59113220 | Nanosuspension Technologies for Delivery of Poorly Soluble Drugs |
| Q39308820 | Novel Pentablock Copolymers as Thermosensitive Self-Assembling Micelles for Ocular Drug Delivery |
| Q40010634 | Novel pentablock copolymer (PLA-PCL-PEG-PCL-PLA) based nanoparticles for controlled drug delivery: Effect of copolymer compositions on the crystallinity of copolymers and in vitro drug release profile from nanoparticles. |
| Q57342122 | Novel thermosensitive hydrogel composites based on poly(d,l-lactide-co-glycolide) nanoparticles embedded in poly(n-isopropyl acrylamide) with sustained drug-release behavior |
| Q55472392 | Ocular Drug, Gene and Cellular Delivery Systems and Advanced Therapy Medicinal Products. |
| Q38318837 | Ocular drug delivery systems: An overview |
| Q35187905 | Ocular pharmacokinetics of dorzolamide and brinzolamide after single and multiple topical dosing: implications for effects on ocular blood flow |
| Q49996892 | Ophthalmic Drug Delivery Systems for Antibiotherapy-A Review |
| Q64249566 | Optimized Preparation of Levofloxacin Loaded Polymeric Nanoparticles |
| Q54195898 | PLGA nanoparticles for intravitreal peptide delivery: statistical optimization, characterization and toxicity evaluation. |
| Q36070388 | PLGA nanoparticles for ocular delivery of loteprednol etabonate: a corneal penetration study. |
| Q38401187 | Parameters and characteristics governing cellular internalization and trans-barrier trafficking of nanostructures |
| Q34707455 | Poly[LA-(Glc-Leu)] copolymer as a carrier for ocular delivery of ciprofloxacin: formulation, characterization and in vivo biocompatibility study |
| Q38955018 | Polymer assisted entrapment of netilmicin in PLGA nanoparticles for sustained antibacterial activity. |
| Q38748582 | Polymeric nanobiocomposites for biomedical applications |
| Q35138918 | Prednisolone-loaded nanocapsules as ocular drug delivery system: development, in vitro drug release and eye toxicity. |
| Q58441742 | Preparation and Characterization of Poly (D,L-Lactide-co-Glycolide) (PLGA) Nanoparticles Loaded with Linamarin for Controlled Drug Release |
| Q42131745 | Preparation and In Vitro/Ex Vivo Evaluation of Moxifloxacin-Loaded PLGA Nanosuspensions for Ophthalmic Application |
| Q39153803 | Preparation and evaluation of charged solid lipid nanoparticles of tetrandrine for ocular drug delivery system: pharmacokinetics, cytotoxicity and cellular uptake studies |
| Q82331574 | Preparation and evaluation of solid lipid nanoparticles of baicalin for ocular drug delivery system in vitro and in vivo |
| Q53655341 | Preparation and ocular pharmacokinetics of hyaluronan acid-modified mucoadhesive liposomes. |
| Q39014772 | Rapamycin-loaded poly(ε-caprolactone)-poly(ethylene glycol)-poly(ε-caprolactone) nanoparticles: preparation, characterization and potential application in corneal transplantation |
| Q37910727 | Recent advances in materials for extended-release antibiotic delivery system |
| Q89909973 | Research progress of in-situ gelling ophthalmic drug delivery system |
| Q44530865 | Retracted: Self-assembled Phenylalanine-α,β-dehydrophenylalanine Nanotubes for Sustained Intravitreal Delivery of a Multi-targeted Tyrosine Kinase Inhibitor. |
| Q42256432 | Rivastigmine-loaded L-lactide-depsipeptide polymeric nanoparticles: decisive formulation variable optimization. |
| Q44736163 | Self-assembled phenylalanine-α,β-dehydrophenylalanine nanotubes for sustained intravitreal delivery of a multi-targeted tyrosine kinase inhibitor |
| Q28364423 | The hen's egg chorioallantoic membrane (HET-CAM) test to predict the ophthalmic irritation potential of a cysteamine-containing gel: Quantification using Photoshop® and ImageJ |
| Q98463547 | Toxic metabolite profiling of Inocybe virosa |
| Q36094986 | pH-Responsive PLGA Nanoparticle for Controlled Payload Delivery of Diclofenac Sodium |
Search more.